Avastin (bevacizumab) Information
Links shared publicly online about this topic.
- 183total visits
Avastin (bevacizumab) Information
fda.gov —
View full resource at fda.gov
Tags: Colorectal Cancer Medication, Avastin
Most Recently Shared on June 29, 2011 at 8:51 pm By:
Stay tuned for story from Internal Medicine News RT @FDA_Drug_Info: CDER Media Statement on Avastin Hearing: http://1.usa.gov/AvastinT
Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS)
oncologytube.com — “Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS): Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS)....” View full resource at oncologytube.com
Most Recently Shared on March 27, 2012 at 11:00 pm By:
In this #video, Clifford A. Hudis, MD talks about the value of progression-free survival - via @oncologytube http://t.co/4NwbT48r
InVite Study in Metastatic Breast Cancer - 23andMe
23andme.com — “The InVite Study is a collaborative effort between 23andMe and Genentech to learn more about how genes influence response to bevacizumab (also known as Avastin?) in the treatment of metastatic breast cancer.” View full resource at 23andme.com
Most Recently Shared on March 21, 2012 at 12:33 pm By:
RT @23andme: 23andMe and Genentech have teamed up for a genetic study in metastatic breast cancer. For more info: http://t.co/y9x2SiXX
Batch of Fake Cancer Drug Turns Up in Israel
safemedicines.org — “Counterfeit drugs are a danger to consumers. Safemedicines.org is the homepage of the Partnership for Safe Medicines, a coalition of patient, physician, pharmacist, academic, and industry groups that work together to educated the public about counterfeit drugs, pharmaceutical, biologics, vaccines, and all other types of fakes and counterfeits. The site holds information on related issues like internet or online pharmacies which might sell counterfeit medication, drug diversion, gray market drugs” View full resource at safemedicines.org
Most Recently Shared on March 1, 2012 at 8:07 pm By:
MT @SafeMedicines Israeli clinics found fake Avastin 2 yrs ago from same batch found here http://t.co/XOnOdJw9
Bevacizumab reported to improve vision in macular degeneration patients
emaxhealth.com — “PHILADELPHIS, PA - The prospect of having to undergo an injection into one’s eyeballs is by no means a welcome thought. However, when the alternativ...” View full resource at emaxhealth.com
Most Recently Shared on February 27, 2012 at 12:46 pm By:
Wills Eye Retina study reports Bevacizumab (Avastin) can improve vision in macular degeneration patients. http://t.co/t7AFKpOK
Fake Avastin (Bevacizumab) Found In USA
medicalnewstoday.com — “Fake cancer drug, Avastin (bevacizumab) has been distributed in the USA, according to statement issued by Roche, Genentech and the FDA (Food and Drug Administration) today. Roche warns that the co” View full resource at medicalnewstoday.com
Most Recently Shared on February 15, 2012 at 11:05 pm By:
Fake Avastin (Bevacizumab) Found In USA http://t.co/F8GwmDCz #pharmacy #pharmacist
When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death - National Cancer Institute
cancer.gov — “Cancer patients who receive the targeted therapy bevacizumab (Avastin) in combination with chemotherapy are at increased risk of serious side effects that may lead to death, according to a meta-analysis of 16 clinical trials that was published February 2,” View full resource at cancer.gov
Most Recently Shared on February 8, 2012 at 5:06 pm By:
When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death http://t.co/XJ5fNGTV
Bevacizumab (Avastin) and Ovarian Cancer | The Citizen Oncologist
citizenoncologist.com — “Bevacizumab (Avastin) and Ovarian Cancer | The Citizen Oncologist” View full resource at citizenoncologist.com
Most Recently Shared on December 30, 2011 at 3:10 pm By:
FDA revokes approval of Avastin as treatment for advanced breast cancer - Daily Dose: A Boston Globe blog with health news, advice, and information.
boston.com — “Thousands of women with advanced breast cancer who are being treated with the drug Avastin may be taken off the drug after the US Food and Drug Adminimstration announced today that is revoking the medication’s approval for treatment of breast cancer. The FDA commissioner, Dr. Margaret A. Hamburg, said she based her decision on studies concluding that the drug has not been shown to be safe or life-extending for women with breast cancer that has spread.” View full resource at boston.com
Most Recently Shared on November 21, 2011 at 8:52 pm By:
Lucentis is a similar drug...FDA revokes approval of Avastin as treatment for advanced breast cancer http://t.co/VuwsSeYk via @BostonDotCom
Medical News: Washington Week: Supreme Court to Take Up ACA - in Washington-Watch, Washington Watch from MedPage Today
medpagetoday.com — “WASHINGTON -- The Supreme Court announced that it will hear the Affordable Care Act (ACA) case this spring, and the FDA announced that bevacizumab (Avastin) is no longer approved to treat metastatic H” View full resource at medpagetoday.com
Most Recently Shared on November 19, 2011 at 5:15 pm By:
Washington Week: Supreme Court to Take Up ACA http://t.co/6xI6ThFW
FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC
news-medical.net — “Genentech, a member of the Roche Group, announced today that the FDA Commissioner is revoking the approval of Avastin (bevacizumab) for the treatment of mBC in the United States.” View full resource at news-medical.net
Most Recently Shared on November 19, 2011 at 6:46 am By:
Stroke News: FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC: Genentech, a member ... http://t.co/6Wt9knP8
FDA Revokes Avastin Approval for Breast Cancer : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on November 18, 2011 at 5:25 pm By:
The FDA is withdrawing approval of bevacizumab, marketed as Avastin, for metastatic breast cancer - http://t.co/P59yrHNo
SAFETY ALERT: FDA Revokes Approval of Avastin for Use in Breast Cancer - MPR
empr.com — “The FDA commissioner, Margaret A. Hamburg, MD, has revoked the approval of Avastin (bevacizumab; Genentech) for the treatment of breast cancer after concluding that the drug has not been shown to be safe and effective for that use.” View full resource at empr.com
Most Recently Shared on November 18, 2011 at 5:03 pm By:
FDA Revokes Avastin Indication for Breast Cancer http://t.co/vf2hgugc #oncology #breastcancer #womenshealth
Avastin (bevacizumab) - Advisories, Warnings & Recalls for the public
hc-sc.gc.ca — “Public Communication 2011/11/14. Health Canada Endorsed Important Safety Information on Avastin (bevacizumab) from Hoffmann-La Roche Limited. An increased risk of ovarian failure in premenopausal women was observed in a clinical trial comparing Avastin plus chemotherapy to chemotherapy alone as adjuvant treatment in patients with colon cancer.” View full resource at hc-sc.gc.ca
Most Recently Shared on November 15, 2011 at 6:28 pm By:
Avastin for colon #cancer increased risk for ovarian failure in pre-menopausal women -- http://t.co/QyTRDtka
Research Interest in Bevacizumab Remains Robust
onclive.com — “Despite controversy over its breast cancer approval status, bevacizumab (Avastin) remains at center stage when it comes to antiangiogenic therapies for the disease.” View full resource at onclive.com
Most Recently Shared on October 6, 2011 at 9:10 pm By:
Research Interest in Bevacizumab (Avastin) Remains Robust http://ow.ly/6PQuQ
Medical News: ECCO-ESMO: Bevacizumab Safe in 'Real World' - in Meeting Coverage, ECCO-ESMO from MedPage Today
medpagetoday.com — “STOCKHOLM -- Treatment of recurrent ovarian cancer with bevacizumab (Avastin) in a real world setting appears to safely produce results observed in clinical trials, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on September 29, 2011 at 2:13 pm By:
ECCO-ESMO: Bevacizumab Safe in 'Real World' (CME/CE) http://t.co/2vN0AO6m
Advertisement

